Entheon Biomedical Corp.
Research Entheon Biomedical Corp. (1XU) on Bullrun: market cap EUR 346.47K, P/E 2.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1XU
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 346.47K
- P/E2.5
- Financial periodQ2 2026
- RevenueCAD 0
- Net incomeCAD 255.20K
- Free cash flowCAD 56.71K
Valuation Snapshot
latest market cap is EUR 346.47K; P/E is 2.5.
Peer valuation comparison
Latest P/E is 2.5x versus a Healthcare sector median of 24.46x (89.8% below).
Latest P/E is 2.5x versus a Canada median of 15.58x (84.0% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 346.47K | 2.5 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Entheon Biomedical Corp.
Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Entheon Biomedical Corp.'s market cap?
Entheon Biomedical Corp.'s market capitalization is EUR 346.47K.
What is Entheon Biomedical Corp.'s P/E ratio?
Entheon Biomedical Corp.'s price-to-earnings (P/E) ratio is 2.5.
What does Entheon Biomedical Corp. do?
Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.